The investor highlights NVIDIA's massive revenue growth and cash flow, boosted by AI demand and strong capital returns. Eli Lilly impresses with high revenue growth driven by key drugs like Mounjaro and Foundayo, despite pricing pressures. Johnson & Johnson offers stability with steady dividend increases and solid revenue growth, offsetting risks from biosimilar competition. These three stocks represent a blend of growth, innovation, and dependable income, making them top picks for rebuilding a portfolio.
Foreign investment in the US jumped 49.5% to $232.2 billion in 2025 after four years of decline, largely due to companies seeking to avoid President Trump's tariffs and benefiting from a weaker US dollar. The largest investments were in publishing, c...
Gold and silver prices fell significantly following the May inflation report and escalating US-Iran tensions. Spot gold dropped 4.26% to around $4,078 an ounce, and silver fell 2.66% to about $63.60. Inflation data showed a 0.5% rise in consumer pric...
In May 2026, three T. Rowe Price ETFs delivered strong returns, led by the Technology ETF (TTEQ) which surged 19.7%, driven largely by Nvidia (NVDA) holdings. NVDA was the top holding across TTEQ, Growth Stock ETF (TGRW), and Innovation Leaders ETF (...
In 2026, the iShares Semiconductor ETF (SOXX) has outperformed the VanEck Semiconductor ETF (SMH) by capturing a broader range of semiconductor stocks, especially equipment makers, resulting in an 86.78% gain versus SMH's 64.11%. SOXX's index favors ...
In 2026, two ETFs with opposite strategies show a clear performance gap: the AI-centric Roundhill Magnificent Seven ETF (MAGS) is down 0.45%, while the broad-market Defiance Large Cap ex-Mag 7 ETF (XMAG) is up 10.73%. MAGS concentrates on seven mega-...
